Predictive value of MRS in bilirubin nerve damage of advanced premature infants

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800019379

Enrollment

Unknown

Registered

2018-11-08

Start date

2019-01-01

Completion date

Unknown

Last updated

2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal hyperbilirubinemia

Interventions

Moderate risk group:none

Low risk group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Advanced premature infants with hyperbilirubinemia

Exclusion criteria

Exclusion criteria: Unhealthy late premature infants

Design outcomes

Primary

Measure	Time frame
MRS;	—

Countries

China

Contacts

Public ContactFengjie Sun

The Fifth Affiliated Hospital of Guangzhou Medical University

sybada2002@163.com+86 15099991537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026